Overview

Resistant Arterial Hypertension Cohort Study

Status:
Completed
Trial end date:
2017-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the epidemiology of resistant hypertension, evaluate the efficacy and feasibility of a standardized drug treatment regimen (including the randomization of two doses of the diuretic used - chlorthalidone), study two interventions in the group of patients that is non-compliant, and study environmental and genetic variables of individuals with resistant hypertension in a family design.
Details
Lead Sponsor:
University Hospital, Geneva
Treatments:
Antihypertensive Agents
Chlorthalidone